rs137852393
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000132.4(F8):c.493C>T(p.Pro165Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000911 in 1,097,715 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000132.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD3 exomes AF: 0.00000545 AC: 1AN: 183420Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67874
GnomAD4 exome AF: 9.11e-7 AC: 1AN: 1097715Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 363081
GnomAD4 genome Cov.: 24
ClinVar
Submissions by phenotype
Hereditary factor VIII deficiency disease Pathogenic:3
Variant summary: F8 c.493C>T (p.Pro165Ser) results in a non-conservative amino acid change located in the Multicopper oxidase-like, N-terminal domain (IPR011707) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 5.5e-06 in 183420 control chromosomes. c.493C>T has been reported in the literature in individuals affected with Factor VIII Deficiency (Hemophilia A) (Lin_1991, Shinozawa_2021). These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in <1% of normal F8 activity (Lin_1991). The following publications have been ascertained in the context of this evaluation (PMID: 8307558, 33254277). ClinVar contains an entry for this variant (Variation ID: 10176). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
- -
- -
not provided Pathogenic:1
The F8 c.493C>T; p.Pro165Ser variant (rs137852393) is reported in the literature in an individual affected with severe hemophilia A (see F8 database and references therein). In vitro functional analyses demonstrate that individuals with this variant have factor VIII activity of <1% (F8 database). This variant is only observed on one allele in the Genome Aggregation Database, indicating it is not a common polymorphism. Additionally, another variant at this codon (c.494C>T, p.Pro165Leu) has been reported in individuals with hemophilia A and is considered pathogenic (Johnsen 2017). Computational analyses predict that this variant is deleterious (REVEL: 0.951). Based on available information, this variant is considered to be pathogenic. References: F8 database: https://f8-db.eahad.org/ Johnsen JM et al. Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life, Our Future initiative. Blood Adv. 2017 May 18;1(13):824-834. PMID: 29296726. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at